|Day Low/High||45.95 / 45.99|
|52 Wk Low/High||22.11 / 46.01|
With earnings season heating up this week, volatility reigned and we added shares to two of our model portfolio positions.
As we prepare for earnings season, we used this week's broad market rally to halve one of our model portfolio positions.
This name is trading higher for a seventh straight session, so we are booking some gains and lowering our rating to a Three.
This week, David Peltier answers questions about portfolio management and healthcare stocks.
We are trimming this position on today's strength, but we expect the company's new products to continue to drive growth.
We used the market's pullback this week to initiate a model portfolio position and add shares to two other names.
Cramer likes what Dominion Resources is doing while Waste Management is leading the disposal pack.
If a company's got growth, a great yield or is mostly domestic, the Fed has sent it an invitation to the market's rally, Cramer said.
During this week's volatile trading, we exited one model portfolio position, trimmed another and added shares to one more.
We used the headline-driven volatility this week to add to one model portfolio position and book some profits in another.
Although easy central bank policies are buoying the market, too many bad earnings announcements could start to matter.
Jim Cramer discusses NPS Pharma and its orphan drug franchise with Nicole Urken, Mad Money Research Director.
Cramer said it's time to get back into SPDR Gold Shares. Hertz is his favorite rental car and NPS is a great orphan drug company.
Believing the bears only keeps investors out of the bull markets.
U.S. stocks continue to trade higher on Tuesdays in 2013, as investors shift their focus away from Cyprus. Portfolio Manager David Peltier highlights early trading action.
This pharmaceutical name is surging on a positive company announcement, making this a good time to lock in some gains.
U.S. stock futures point to slight gains on Wall Street; Electronic Arts CEO is resigning; Lululemon pulls certain yoga pants from stores; Adobe to report earnings.
Takeda decides Revestive is no longer a strategic asset.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and Takeda Pharmaceutical Company Limited (TSE: 4502, “Takeda”) announced today that NPS has re-gained the full worldwide rights to teduglutide (trade name in ...
During a volatile, quadruple-witching options expiration week, we used rallies to book profits in two model portfolio names.
As the Russell 2000 moved to new highs this week, we added shares to one model portfolio name and trimmed another one.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Barclays Capital Global Healthcare Conference in Miami, Florida on Wednesday, March 13, 2013 at 11:15 a.
We used the volatile trading action in the market this week to add to two of our model portfolio positions.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, is joining the National Organization for Rare...
This week, we took advantage of opportunities to put cash to work and add shares to two of our model portfolio positions.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the fourth quarter...
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 26, 2013 at 10:00 AM ET.
We used this week's trading action to book some profits in one model portfolio name and add shares to three other positions.
We're adding to this promising pharmaceutical holding on broad-market weakness.
NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its 2012 financial results on Thursday, February 21, 2013 at approximately 4:00 p.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.